Article

Evaluation of Seropositivity after Standard Doses of Vaccination against SARS-CoV-2 in…

medRxiv: the preprint server for health sciences · 2022 · Jinyong Kim, author Euijin Chang, author Song Yi Park, author Dae-Won Lee, author Chang Kyung Kang, author Pyoeng Gyun Choe, author Nam Joong Kim, author Myoung-don Oh, author Wan Beom Park, author Kyung-Hun Lee, author Seock-Ah Im, author

Key facts

Title Evaluation of Seropositivity after Standard Doses of Vaccination against SARS-CoV-2 in Early Breast Cancer Patients Receiving Adjuvant Treatment
First author Jinyong Kim, author Euijin Chang, author Song Yi Park, author Dae-Won Lee, author Chang Kyung Kang, author Pyoeng Gyun Choe, author Nam Joong Kim, author Myoung-don Oh, author Wan Beom Park, author Kyung-Hun Lee, author Seock-Ah Im, author
Journal medRxiv : the preprint server for health sciences
Published Jul 26, 2022
DOI 10.1101/2022.07.23.22277888
Devices mentioned K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186, K854187 and 1 more
Product codes mentioned CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 1 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature